Annual Drug Patent Expirations for ACUVAIL
Acuvail is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and two Paragraph IV challenges.
This drug has fifty-five patent family members in twenty-five countries.
The generic ingredient in ACUVAIL is ketorolac tromethamine. One supplier is listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
